Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Onclarity™ Self-Collection Kit

K-Number: K260184 · 2026-04-02

ApplicantBecton, Dickinson and Company
Decision Date2026-04-02
Product CodeSEP
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

Onclarity™ Self-Collection Kit is the device name listed in this FDA 510(k) record. The listed applicant is Becton, Dickinson and Company. It received FDA 510(k) clearance on 2026-04-02 under 510(k) number K260184. The device is classified under product code SEP. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Onclarity™ Self-Collection Kit?

Onclarity™ Self-Collection Kit is a medical device that received FDA 510(k) clearance on 2026-04-02. The listed applicant is Becton, Dickinson and Company. The 510(k) number is K260184.

When did Onclarity™ Self-Collection Kit receive FDA 510(k) clearance?

Onclarity™ Self-Collection Kit received FDA 510(k) clearance on 2026-04-02, under 510(k) number K260184.

Who is the listed applicant for Onclarity™ Self-Collection Kit?

The FDA 510(k) record lists Becton, Dickinson and Company as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Onclarity™ Self-Collection Kit?

The FDA product code for Onclarity™ Self-Collection Kit is SEP.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT05957406SMART TRENDS StudyCOMPLETEDNCT06492746Personal BP - CAI StudyRECRUITINGNCT07148323HemoSphere Alta StudyRECRUITINGNCT07216573The Continuity StudyRECRUITINGNCT07317648ClearSight NextGen1 StudyCOMPLETEDNCT06825689Unidos Contra el VPHRECRUITING

Other records listing Becton, Dickinson and Company as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

PMA P160037KIT, DNA DETECTION, HUMAN PAPILLOMAVIRUSK260128BD Preset™ and BD A-Line™ Arterial Blood Collection SyringesK252506BD Vacutainer® Safety-Lok™ Blood Collection Set; BD Vacutainer® Safety-Lok™ Blood Collection Set with Pre-Attached HolderK252378BD® MiniDraw™ Capillary Blood Collection System with BD® MiniDraw™ SST™ Capillary Blood Collection TubeK252040BD Vacutainer® Plasma Separator Tubes (PST™), BD Vacutainer® Sodium Heparin Blood Collection TubesK2508840.9 % Sodium Chloride Injection, USP, BD PosiFlush™ SP Syringe

View all 100 devices →

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑